Trial intelligence / Profile preview

Dexmedetomidine in transsphenoidal surgery for pituitary tumors

NCT02549768Phase 4Unknown

Sponsor
Pontificia Universidad Católica de Chile
Start
Sep 2015
Primary completion
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine in pituitary neoplasm, sponsored by Pontificia Universidad Católica de Chile. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

pituitary neoplasm

Beyond the preview

Go deeper on NCT02549768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02549768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call